To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
Podcast 92: Corticosteroids in COPD exacerbations — high-dose intravenous or low-dose oral?
Joe Elia • June 18th, 2010
Categories: Audio, chronic obstructive pulmonary disease, COPD, corticosteroids, Uncategorized
A JAMA paper suggests that in all but the most severe exacerbations of COPD, it’s best to start off with low-dose oral corticosteroids rather than the higher-dose intravenous treatment that, contrary to guideline recommendations, almost everyone now gets. Our conversation this week is with the study’s first author, Dr. Peter Lindenauer.
Visit the Journal Watch website at http://jwatch.org for a comprehensive look at new medical research, with comments from our experts.
- COPD guidelines from the Global Initiative for Chronic Obstructive Lung Disease
- JAMA article abstract
- Increased cancer risk with ARBs
- Diabetes, its treatments, and cancer risks
- FDA announces review of olmesartan
- FDA’s MedWatch reporting site